Stay updated with breaking news from Nasdaq Amph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a hold rating to a buy rating in a research note released on Friday morning. Separately, Bank of America started coverage on Amphastar Pharmaceuticals in a research note on Friday, November 17th. They issued a neutral rating and a $63.00 price objective on the […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $61.37, for a total transaction of $30,685.00. Following the sale, the director now owns 80,833 shares in the […]
Shariaportfolio Inc. acquired a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 12,505 shares of the company’s stock, valued at approximately $575,000. Other institutional investors and hedge funds […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report)’s stock price shot up 2.4% during trading on Friday . The company traded as high as $65.92 and last traded at $64.99. 97,849 shares were traded during trading, a decline of 76% from the average session volume of 399,794 shares. The stock had previously closed at $63.45. […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) shares traded up 2.4% on Friday . The stock traded as high as $65.92 and last traded at $64.99. 97,849 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 399,794 shares. The stock had previously closed at $63.45. Wall Street […]